Abstract
Cannabigerol (CBG) is the precursor of major phytocannabinoids (pCBs) like cannabidiol (CBD), and delta-9-tetrahydrocannabinol (THC) which are widely studied owing to their clinical benefits. However, pCBs are still not widely accepted as drugs which have led to increasing research in understanding the metabolic pathway of phytocannabinoids (pCBs) as well as their disposition within our body. Herein we have used biophysical tools like UV-Vis and fluorescence spectroscopy to study the binding of different liver Cytochrome P450 (CYP) with pCBs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
